Christopher R. Fenimore - 31 Mar 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Controller
Signature
/s/**Christopher R. Fenimore
Issuer symbol
REGN
Transactions as of
31 Mar 2022
Transactions value $
-$2,250,727
Form type
4
Filing time
01 Apr 2022, 16:07:40 UTC
Previous filing
14 Dec 2021
Next filing
11 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1.11M +2K +9.33% $555.67 23.4K 31 Mar 2022 Direct
transaction REGN Common Stock Tax liability -$1.26M -1.8K -7.67% $700.99 21.6K 31 Mar 2022 Direct
transaction REGN Common Stock Options Exercise $2.7M +10K +46.24% $270.43 31.6K 31 Mar 2022 Direct
transaction REGN Common Stock Tax liability -$4.81M -6.86K -21.68% $700.99 24.8K 31 Mar 2022 Direct
holding REGN Common Stock 1.78K 31 Mar 2022 2021 GRAT
holding REGN Common Stock 1.46K 31 Mar 2022 By 401(k) Plan
holding REGN Common Stock 1.9K 31 Mar 2022 By Trust F1
holding REGN Common Stock 1.35K 31 Mar 2022 by 2018 GRAT
holding REGN Common Stock 25 31 Mar 2022 by Trust for Daugh
holding REGN Common Stock 25 31 Mar 2022 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -50% $0.00 10K 31 Mar 2022 Common Stock 10K $270.43 Direct F2
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2K -13.84% $0.00 12.5K 31 Mar 2022 Common Stock 2K $555.67 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.